Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)

BACKGROUND: Moderate hypofractionation is the recommended standard of care for localised prostate cancer following the results of trials including Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy in Prostate Cancer (CHHiP). Evaluation of long-term patient-reported outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Staffurth, John N., Haviland, Joanne S., Wilkins, Anna, Syndikus, Isabel, Khoo, Vincent, Bloomfield, David, Parker, Chris, Logue, John, Scrase, Christopher, Birtle, Alison, Malik, Zafar, Panades, Miguel, Eswar, Chinnamani, Graham, John, Russell, Martin, Ferguson, Catherine, O’Sullivan, Joe M., Cruickshank, Clare A., Dearnaley, David, Hall, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674146/
https://www.ncbi.nlm.nih.gov/pubmed/34489210
http://dx.doi.org/10.1016/j.euo.2021.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674146/
https://www.ncbi.nlm.nih.gov/pubmed/34489210
http://dx.doi.org/10.1016/j.euo.2021.07.005

Ejemplares similares